1. Home
  2. INMD vs CERT Comparison

INMD vs CERT Comparison

Compare INMD & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InMode Ltd.

INMD

InMode Ltd.

HOLD

Current Price

$14.02

Market Cap

842.0M

Sector

Health Care

ML Signal

HOLD

CERT

Certara Inc.

HOLD

Current Price

$4.67

Market Cap

860.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
INMD
CERT
Founded
2008
2008
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
842.0M
860.9M
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
INMD
CERT
Price
$14.02
$4.67
Analyst Decision
Hold
Buy
Analyst Count
5
10
Target Price
$17.33
$11.67
AVG Volume (30 Days)
716.6K
3.0M
Earning Date
05-06-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
87.50
EPS
N/A
N/A
Revenue
N/A
$418,838,000.00
Revenue This Year
$1.74
$4.18
Revenue Next Year
$3.26
$5.39
P/E Ratio
$10.11
N/A
Revenue Growth
N/A
8.75
52 Week Low
$12.72
$4.45
52 Week High
$16.74
$13.88

Technical Indicators

Market Signals
Indicator
INMD
CERT
Relative Strength Index (RSI) 49.24 29.39
Support Level $14.00 N/A
Resistance Level $14.70 $6.47
Average True Range (ATR) 0.30 0.31
MACD -0.02 -0.14
Stochastic Oscillator 59.92 11.22

Price Performance

Historical Comparison
INMD
CERT

About INMD InMode Ltd.

InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.

About CERT Certara Inc.

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.

Share on Social Networks: